Risk factors for gastrointestinal bleeding associated with low-dose aspirin
- 30 April 2012
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Gastroenterology
- Vol. 26 (2), 125-140
- https://doi.org/10.1016/j.bpg.2012.01.011
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional AssessmentClinical Gastroenterology and Hepatology, 2009
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation, 2007
- Assessing the Burden of Disease in the United States Using Disability-Adjusted Life YearsAmerican Journal of Preventive Medicine, 2005
- Nonsteroidal antiinflammatory drugs and the small intestineCurrent Opinion in Gastroenterology, 2005
- Incidence of serious upper gastrointestinal bleeding/perforation in the general population:: Review of epidemiologic studiesJournal of Clinical Epidemiology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United KingdomBMJ, 1995
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989